title: Very early risk stratification using combined ECG and biochemical assessment in patients with unstable coronary artery disease (A thrombin inhibition in myocardial ischemia [TRIM] substudy). The TRIM Study Group.
abstract: BACKGROUND
  The diagnostic capability of troponin T (TnT), troponin I (TnI), myoglobin, and creatine kinase (CK)-MB mass for detection of myocardial injury seems evident. Newer studies have found these sensitive markers to carry independent prognostic information in patients with unstable coronary artery disease as well. ST-segment depression in the admission ECG is known to be an important indicator of poor outcome in these patients. The present study investigates the prognostic capacities of the ECG in combination with biochemical admission measurements in 516 patients admitted to hospital with unstable coronary artery disease.
  
  
  RESULTS
  Baseline ECG recordings and blood samples were collected for central analysis. The patients were followed up for 30 days, and predefined end points, ie, death, myocardial infarction, and refractory angina, were registered as end points. By univariate analysis, ST-segment depression, inverted T waves in >/=5 leads, TnT >/=0.1 microg/L, TnI >/=0.5 microg/L, myoglobin >/=40 microg/L, female sex, and age >/=65 years were predictors of death and myocardial infarction at 30 days. By multivariate analysis, female sex, ST-segment depression at randomization, or inverted T-waves in >/=5 leads were the only independent predictors of death or myocardial infarction. On the basis of baseline ECG ST-T changes and CK-MB mass/TnT/TnI/myoglobin levels, the patients were divided into 3 subgroups at high (14% event rate), intermediate (6%), and low (3%) risk of early death/myocardial infarction.
  
  
  CONCLUSIONS
  The present study found the combination of baseline values of TnT, TnI, CK-MB mass, and ST-T changes in the ECG to be effective for early risk stratification in patients with unstable coronary artery disease.
authors.affiliation: Heart Center, Rigshospitalet, Copenhagen, and the Department of Cardiology, Aarhus Amtssygehus/Universitetshospital, Aarhus, Denmark.
authors.forename: L
authors.initials: L
authors.lastname: Holmvang
authors.forename: M S
authors.initials: MS
authors.lastname: Lüscher
authors.forename: P
authors.initials: P
authors.lastname: Clemmensen
authors.forename: K
authors.initials: K
authors.lastname: Thygesen
authors.forename: P
authors.initials: P
authors.lastname: Grande
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000789:Angina, Unstable / Q000188:drug therapy; D000991:Antithrombins / Q000627:therapeutic use; D015415:Biomarkers; D003327:Coronary Disease / Q000378:metabolism / Q000503:physiopathology*; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000188:drug therapy; D011379:Prognosis; D018570:Risk Assessment; D013917:Thrombin / Q000037:antagonists & inhibitors; D013997:Time Factors
chemical_list: D000991:Antithrombins; D015415:Biomarkers; D013917:Thrombin